Skip to main content
. 2020 Apr 10;117(17):9292–9301. doi: 10.1073/pnas.2000963117

Fig. 2.

Fig. 2.

AMPK inhibits IIS in Drosophila. (A) Developmental phosphorylation profile of AMPK, AKT, InR, S6K, and 4EBP in the Drosophila fat body at different stages (feeding, EW, LW, WPP, and 6 h after pupation). (B) Developmental profiles of mRNA levels of AMPKα (blue), AMPKβ (red), and AMPKγ (green) in the Drosophila fat body and ecdysteroid titers (72, 73) at different stages. Fold-changes shown are relative to Rp49. (C) Phosphorylation levels of InR, AKT, S6K, and 4EBP were decreased in Adh-Gal4 > UAS-AMPKCA. Adh-Gal4 drives fat body-specific Gal4 expression. (D) Phosphorylation levels of InR, AKT, S6K, and 4EBP were increased in Lsp2-Gal4 > UAS-AMPKDN. Lsp2-Gal4 also drives fat body-specific Gal4 expression. (E) The Flp-out experiment revealing that the activity of PI3K is inhibited in red-positive clones in HsFlpase; Act > CD2 > Gal4, UAS-RFP, tGPH; UAS-AMPKCA at the feeding stage. RFP (red), tGPH (green). (F) The Flp-out experiment revealing that the activity of PI3K is increased in red-positive clones in HsFlpase; Act > CD2 > Gal4, UAS-RFP, tGPH::UAS-AMPKDN at the LW stage. RFP (red), tGPH (green).